A detailed history of Logos Global Management LP transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 2,000,000 shares of COGT stock, worth $15.7 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
2,000,000
Holding current value
$15.7 Million
% of portfolio
2.86%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.24 - $11.48 $16.5 Million - $23 Million
2,000,000 New
2,000,000 $21.6 Million
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.24 $1.97 Million - $2.65 Million
-200,000 Reduced 20.0%
800,000 $9.47 Million
Q1 2023

May 15, 2023

SELL
$10.04 - $15.5 $1 Million - $1.55 Million
-100,000 Reduced 9.09%
1,000,000 $10.8 Million
Q4 2022

Feb 14, 2023

BUY
$10.65 - $14.84 $11.7 Million - $16.3 Million
1,100,000 New
1,100,000 $12.7 Million
Q2 2022

Aug 15, 2022

SELL
$3.92 - $9.73 $588,000 - $1.46 Million
-150,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$7.51 - $10.81 $5.82 Million - $8.38 Million
-775,000 Reduced 83.78%
150,000 $1.29 Million
Q3 2021

Nov 15, 2021

SELL
$5.99 - $9.14 $2.97 Million - $4.53 Million
-495,500 Reduced 34.88%
925,000 $7.78 Million
Q1 2021

May 17, 2021

SELL
$7.47 - $12.34 $3.74 Million - $6.17 Million
-500,000 Reduced 26.03%
1,420,500 $12.5 Million
Q4 2020

Feb 16, 2021

BUY
$9.04 - $13.01 $17.4 Million - $25 Million
1,920,500 New
1,920,500 $21.6 Million

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $516M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.